
    
      Multi-center, Randomized, Controlled Clinical Trial to Evaluate the Efficacy and Safety of
      Adjuvant Thymalfasin Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma
      After Curative Resection.
    
  